Cargando…

Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy

Hepatocellular carcinoma is today the sixth leading cause of cancer-related death worldwide, despite the decreased incidence of chronic hepatitis infections. This is due to the increased diffusion of metabolic diseases such as the metabolic syndrome, diabetes, obesity, and nonalcoholic steatohepatit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gnocchi, Davide, Sabbà, Carlo, Massimi, Mara, Mazzocca, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964410/ https://www.ncbi.nlm.nih.gov/pubmed/36835122 http://dx.doi.org/10.3390/ijms24043710

Ejemplares similares

The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer
por: Gnocchi, Davide, et al.
Publicado: (2022)

Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis
por: Gnocchi, Davide, et al.
Publicado: (2023)

(1)H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth
por: Gnocchi, Davide, et al.
Publicado: (2021)

The perplexity of targeting genetic alterations in hepatocellular carcinoma
por: Barone, Michele, et al.
Publicado: (2020)

Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis
por: Custodero, Carlo, et al.
Publicado: (2022)

Brain metastases from hepatocellular carcinoma: recent advances and future avenues
por: Wang, Shanshan, et al.
Publicado: (2017)

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
por: Divella, Rosa, et al.
Publicado: (2019)

Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
por: Massimi, Mara, et al.
Publicado: (2019)

Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy
por: Kee, Hyun Jung, et al.
Publicado: (2014)

New Avenues for Nanoparticle-Related Therapies
por: Zhao, Michael, et al.
Publicado: (2018)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

New Avenues for the Treatment of Huntington’s Disease
por: Kim, Amy, et al.
Publicado: (2021)

New Avenues of Heme Synthesis Regulation
por: Medlock, Amy E., et al.
Publicado: (2022)

Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
por: Choe, Jung Wan, et al.
Publicado: (2022)

New avenues for therapy in mitochondrial optic neuropathies
por: Ng, Wing Sum Vincent, et al.
Publicado: (2021)

Transcriptional addiction in mixed lineage leukemia: new avenues for target therapies
por: Xiao, Ruijing, et al.
Publicado: (2019)

Dexmedetomidine: New avenues
por: Grewal, Anju
Publicado: (2011)

Nanobodies: new avenue to treat kidney disease
por: Wanner, Nicola, et al.
Publicado: (2021)

Viruses with U-DNA: New Avenues for Biotechnology
por: Nagy, Kinga K., et al.
Publicado: (2021)

Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications
por: Rai, Raj, et al.
Publicado: (2019)

Quantitative Epigenetics: A New Avenue for Crop Improvement
por: Gahlaut, Vijay, et al.
Publicado: (2020)

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
por: Mossenta, Monica, et al.
Publicado: (2019)

Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues
por: Bhatnagar, Roshni, et al.
Publicado: (2022)

New avenues for regulation of lipid metabolism by thyroid hormones and analogs
por: Senese, Rosalba, et al.
Publicado: (2014)

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013)

Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma
por: Leite, Taiana Campos, et al.
Publicado: (2021)

miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy
por: Sabir, Naveed, et al.
Publicado: (2018)

CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement
por: Pant, Ayush, et al.
Publicado: (2023)

Periodontal disease and its prevention, by traditional and new avenues
por: Mann, Jonathan, et al.
Publicado: (2020)

New Promising Therapeutic Avenues of Curcumin in Brain Diseases
por: Benameur, Tarek, et al.
Publicado: (2021)

Congenital Zika Syndrome: Genetic Avenues for Diagnosis and Therapy, Possible Management and Long-Term Outcomes
por: Gullo, Giuseppe, et al.
Publicado: (2022)

Neuromodulation as a new avenue for resuscitation in hemorrhagic shock
por: Powell, Keren, et al.
Publicado: (2019)

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
por: Bhat, Ajaz A., et al.
Publicado: (2021)

New Avenues in Pharmaceutical Education
por: Udupa, N.
Publicado: (2011)

New Avenues in Management of Trichotillomania
por: Chawla, Omna, et al.
Publicado: (2013)

New avenues in cardio-oncology
por: Sala, Valentina, et al.
Publicado: (2019)

Nanomedicine has opened new avenues for cancer diagnosis and therapy
por: Dai, Zhi-Fei
Publicado: (2016)

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
por: Singh, Rajan, et al.
Publicado: (2021)

Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism
por: Gnocchi, Davide, et al.
Publicado: (2015)

Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
por: Roth, Sanford H
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m773pbhm1e79055ia196qk55b4